紅相股份(300427.SZ):公司技術中心被認定為國家企業技術中心
格隆匯2月24日丨紅相股份(300427.SZ)公佈,近日,公司從中華人民共和國國家發展和改革委員會網站獲知,國家發展改革委、科技部、財政部、海關總署、税務總局聯合下發了《關於印發2021年(第28批)新認定及全部國家企業技術中心名單的通知》(發改高技[2022]158號)。根據該通知,紅相股份技術中心被認定為2021年(第28批)國家企業技術中心。
公司技術中心被認定為國家企業技術中心,是對公司技術創新能力及研發能力的充分肯定,有利於公司進一步提升自主創新能力和核心競爭力。公司將繼續加大技術創新投入,加強研發團隊能力建設,充分發揮國家企業技術中心在公司發展中的積極作用,促進公司持續健康發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.